Chlorine in PDB 8f0s: Structure of VSD4-NAV1.7-Navpas Channel Chimera Bound to the Hybrid Inhibitor Gne-9296

The structure of Structure of VSD4-NAV1.7-Navpas Channel Chimera Bound to the Hybrid Inhibitor Gne-9296 also contains other interesting chemical elements:

Fluorine

(F)

2 atoms

The binding sites of Chlorine atom in the Structure of VSD4-NAV1.7-Navpas Channel Chimera Bound to the Hybrid Inhibitor Gne-9296 (pdb code 8f0s). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure of VSD4-NAV1.7-Navpas Channel Chimera Bound to the Hybrid Inhibitor Gne-9296, PDB code: 8f0s:

Chlorine binding site 1 out of 1 in the Structure of VSD4-NAV1.7-Navpas Channel Chimera Bound to the Hybrid Inhibitor Gne-9296


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Structure of VSD4-NAV1.7-Navpas Channel Chimera Bound to the Hybrid Inhibitor Gne-9296 within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl1605 b:26.7 occ:1.00 CL01 A:X801605 0.0 26.7 1.0 C18 A:X801605 1.7 26.7 1.0 C17 A:X801605 2.7 26.7 1.0 C19 A:X801605 2.7 26.7 1.0 O04 A:X801605 2.9 26.7 1.0 C16 A:X801605 4.0 26.7 1.0 C26 A:X801605 4.0 26.7 1.0 C20 A:X801605 4.0 26.7 1.0 CD1 A:ILE1254 4.1 36.7 1.0 CG1 A:ILE1267 4.1 25.7 1.0 CA A:GLY1247 4.2 28.2 1.0 O A:GLY1247 4.3 28.2 1.0 CA A:ALA1251 4.3 34.6 1.0 CG2 A:ILE1267 4.3 25.7 1.0 O A:ILE1267 4.3 25.7 1.0 CB A:ALA1251 4.4 34.6 1.0 N A:ALA1251 4.5 34.6 1.0 C27 A:X801605 4.5 26.7 1.0 C A:ILE1267 4.6 25.7 1.0 CA A:ARG1268 4.6 22.8 1.0 N A:ARG1268 4.7 22.8 1.0 C A:GLY1247 4.7 28.2 1.0 C A:LEU1250 4.8 34.6 1.0 CB A:ILE1267 4.8 25.7 1.0 CE1 A:PHE1264 4.9 29.8 1.0

M.Kschonsak, C.C.Jao, C.P.Arthur, A.L.Rohou, P.Bergeron, D.F.Ortwine, S.J.Mckerrall, D.H.Hackos, L.Deng, J.Chen, T.Li, P.S.Dragovich, M.Volgraf, M.R.Wright, J.Payandeh, C.Ciferri, J.C.Tellis. Cryo-Em Reveals An Unprecedented Binding Site For Na V 1.7 Inhibitors Enabling Rational Design of Potent Hybrid Inhibitors. Elife V. 12 2023.
ISSN: ESSN 2050-084X
PubMed: 36975198
DOI: 10.7554/ELIFE.84151